Rockwell Medical, Inc.
Index- P/E- EPS (ttm)-31.49 Insider Own6.70% Shs Outstand10.68M Perf Week-16.99%
Market Cap14.30M Forward P/E- EPS next Y-1.67 Insider Trans0.00% Shs Float9.73M Perf Month-24.40%
Income-32.10M PEG- EPS next Q-0.48 Inst Own18.60% Short Float1.03% Perf Quarter-14.77%
Sales62.60M P/S0.23 EPS this Y-838.20% Inst Trans-9.07% Short Ratio1.07 Perf Half Y-69.54%
Book/sh2.29 P/B0.55 EPS next Y25.60% ROA-56.20% Target Price6.00 Perf Year-81.90%
Cash/sh2.74 P/C0.46 EPS next 5Y38.00% ROE-395.60% 52W Range1.17 - 7.34 Perf YTD-71.84%
Dividend- P/FCF- EPS past 5Y-57.90% ROI- 52W High-83.17% Beta1.10
Dividend %- Quick Ratio2.30 Sales past 5Y3.10% Gross Margin-5.80% 52W Low5.56% ATR0.14
Employees300 Current Ratio2.50 Sales Q/Q23.80% Oper. Margin-42.30% RSI (14)33.54 Volatility5.06% 8.85%
OptionableYes Debt/Eq0.85 EPS Q/Q42.80% Profit Margin-45.80% Rel Volume0.26 Prev Close1.27
ShortableYes LT Debt/Eq0.52 EarningsAug 15 BMO Payout- Avg Volume93.90K Price1.24
Recom2.00 SMA20-20.39% SMA50-21.57% SMA200-58.29% Volume23,065 Change-2.76%
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Nov-06-13Reiterated Summer Street Research Buy
Sep-05-13Reiterated Summer Street Research Buy $20 → $25
Aug-02-13Reiterated Summer Street Research Buy $20
Apr-11-12Initiated Summer Street Research Buy $20
Mar-12-12Initiated Stifel Nicolaus Buy $15
Jan-03-12Initiated Canaccord Genuity Buy $14
Dec-10-09Initiated JMP Securities Mkt Outperform $11
Oct-12-09Initiated Wedbush Morgan Outperform $12
Sep-14-22 04:15PM
Sep-07-22 08:00AM
Sep-02-22 07:03AM
Aug-30-22 01:27PM
Aug-18-22 08:50AM
Aug-15-22 06:00AM
Aug-03-22 06:00AM
Jun-24-22 08:56AM
Jun-23-22 07:07AM
Jun-22-22 04:02PM
Jun-07-22 08:00AM
Jun-01-22 08:00AM
May-31-22 08:00AM
May-23-22 08:00AM
May-16-22 04:02PM
May-12-22 10:53AM
May-11-22 08:00AM
Apr-29-22 08:25AM
Apr-25-22 08:00AM
Apr-20-22 08:00AM
Apr-11-22 09:00AM
Mar-15-22 09:00AM
Mar-09-22 09:00AM
Mar-01-22 08:55AM
Feb-15-22 08:30AM
Feb-14-22 04:05PM
Jan-20-22 09:15AM
Jan-14-22 03:05PM
Jan-13-22 11:42AM
Jan-07-22 12:00PM
Dec-14-21 09:00AM
Nov-17-21 02:39PM
Nov-16-21 04:01PM
Nov-15-21 05:15PM
Nov-12-21 04:05PM
Nov-11-21 08:30AM
Nov-08-21 07:00AM
Nov-04-21 04:01PM
Nov-01-21 03:01PM
Sep-09-21 09:52AM
Aug-19-21 04:00PM
Aug-16-21 06:35PM
Aug-09-21 03:00PM
Jul-29-21 07:00AM
Jun-28-21 07:00AM
Jun-18-21 12:52PM
Jun-14-21 08:07AM
Jun-11-21 12:20PM
Jun-08-21 07:00AM
Jun-07-21 09:29AM
Jun-03-21 07:00AM
May-17-21 04:05PM
May-03-21 07:00AM
Apr-27-21 07:00AM
Apr-26-21 06:29AM
Apr-22-21 04:05PM
Apr-06-21 10:08AM
Mar-31-21 05:45PM
Mar-26-21 12:34PM
Mar-24-21 12:30PM
Mar-18-21 07:00AM
Mar-17-21 08:34AM
Mar-04-21 12:30PM
Feb-09-21 01:45PM
Feb-01-21 08:08AM
Jan-14-21 08:47AM
Jan-13-21 07:00AM
Jan-05-21 07:00AM
Dec-16-20 07:00AM
Dec-02-20 04:07AM
Nov-29-20 04:57PM
Nov-09-20 05:02PM
Nov-02-20 12:30PM
Oct-27-20 08:00AM
Oct-13-20 08:00AM
Sep-24-20 06:09PM
Sep-23-20 08:45AM
Sep-22-20 09:52AM
Sep-21-20 03:30PM
Sep-15-20 07:59AM
Sep-11-20 10:09AM
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.